Vivos Therapeutics said Wednesday the Food and Drug Administration has granted 510 clearance for its oral device treatment for severe obstructive sleep apnea in adults.
The clearance is for its.
Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund 0.2% softer.
The iShares Biotechnology ETF was.